Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo

Abstract

We had characterized earlier the novel tumor suppressor gene hepatocellular carcinoma suppressor 1 (HCCS1), and demonstrated that expression of exogenous HCCS1 gene in human hepatocarcinoma cells could remarkably suppress their abilities to develop tumors in nude mice and to form colonies in soft agar. In this study, we provide further experimental evidence to confirm the role of HCCS1 as a tumor suppressor gene and investigate its potential in therapeutic applications by using adenovirus vectors. We show that HCCS1 overexpression, mediated by replication-deficient adenovirus, significantly suppressed the growth of human colorectal cancer cells, as well as hepatocellular carcinoma cells in vitro and in vivo. To further improve its antitumor efficacy, we inserted the HCCS1 gene into an oncolytic adenovirus. This HCCS1-armed oncolytic adenovirus exhibited a dramatic inhibitory effect on cancer cells in vitro and in vivo, and led to a complete regression of 50% of established tumor xenografts in nude mice. Taken together, our data suggest that HCCS1 is a promising therapeutic gene for the treatment of human cancers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Kondoh N, Wakatsuki M, Hada A, Shuda M, Tanaka K, Arai M et al. Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 2001; 18: 1271–1278.

    CAS  PubMed  Google Scholar 

  2. Zhao XT, Li J, He Y, Lan F, Fu L, Guo J et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res 2001; 61: 7383–7387.

    CAS  PubMed  Google Scholar 

  3. Zhao X, He M, Wan D, Ye Y, He Y, Han L et al. The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 2003; 190: 221–232.

    Article  CAS  Google Scholar 

  4. Vile RG, Russell SJ, Lemoine NR . Cancer gene therapy: hard lessons and new courses. Gene Therapy 2000; 7: 2–8.

    Article  CAS  Google Scholar 

  5. Vorburger SA, Hunt KK . Adenoviral gene therapy. Oncologist 2002; 7: 46–59.

    Article  CAS  Google Scholar 

  6. Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 2003; 13: 481–489.

    Article  CAS  Google Scholar 

  7. Liu XY, Gu JF . Targeting gene-virotherapy of cancer. Cell Res 2006; 16: 25–30.

    Article  Google Scholar 

  8. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87: 7555–7559.

    Article  CAS  Google Scholar 

  9. Zhao H, Xu Y . Mad-overexpression down regulates the maliganant growth and p53 mediated apoptosis in human hepatocellular carcinoma BEL7404 cells. Cell Res 1999; 9: 51–59.

    Article  CAS  Google Scholar 

  10. Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R et al. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology 2004; 39: 1371–1381.

    Article  CAS  Google Scholar 

  11. Liu XY, Qiu SB, Zou WG, Pei ZF, Gu JF, Luo CX et al. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5. Mol Ther 2005; 11: 531–541.

    Article  CAS  Google Scholar 

  12. Zhang Z, Zou W, Wang J, Gu J, Dang Y, Li B et al. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1. Mol Ther 2005; 11: 553–562.

    Article  CAS  Google Scholar 

  13. Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L et al. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer. Hum Gene Ther 2005; 16: 845–858.

    Article  CAS  Google Scholar 

  14. Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J et al. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy. Caner Res 2006; 66: 4291–4298.

    Article  CAS  Google Scholar 

  15. Qi R, Gu G, Zhang Z, Yang K, Li B, Fan J et al. Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis. Cancer Gene Ther 2007; 14: 82–90.

    Article  CAS  Google Scholar 

  16. Gan Y, Zhao X, Hu J, Wang Z, Zhao X . HCCS1 overexpression induces apoptosis via cathepsin D and intracellular calcium, and HCCS1 disruption in mice causes placental abnormality. Cell Death Differ 2008 May 30, [E-pub ahead of print; doi:10.1038/cdd.2008.73].

  17. Guicciardi ME, Leist M, Gores GJ . Lysosomes in cell death. Oncogene 2004; 23: 2881–2890.

    Article  CAS  Google Scholar 

  18. Chwieralski CE, Welte T, Bühling F . Cathepsin-regulated apoptosis. Apoptosis 2006; 11: 143–149.

    Article  CAS  Google Scholar 

  19. Kos J, Lah TT . Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 1998; 5: 1349–1361.

    CAS  PubMed  Google Scholar 

  20. Koblinski JE, Ahram M, Sloane BF . Unraveling the role of proteases in cancer. Clin Chim Acta 2000; 291: 113–135.

    Article  CAS  Google Scholar 

  21. Fehrenbacher N, Jäättelä M . Lysosomes as targets for cancer therapy. Cancer Res 2005; 65: 2993–2995.

    Article  CAS  Google Scholar 

  22. Conibear E, Stevens TH . Vps52p, Vps53p, and Vps54p form a novel multisubunit complex required for protein sorting at the yeast late Golgi. Mol Biol Cell 2000; 11: 305–323.

    Article  CAS  Google Scholar 

  23. Leiwen H, Meinhold-Heerlein I, Oliveira V, Schwarzenbacher R, Luo G, Wadle A et al. Characterization of the human GARP (Golgi associated retrograde protein) complex. Exp Cell Res 2005; 306: 24–34.

    Article  Google Scholar 

  24. Press B, Feng Y, Hoflack B, Wandinger-Ness A . Mutant rab7 causes the accumulation of cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment. J Cell Biol 1998; 140: 1075–1089.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Lanying Sun for her excellent technical assistance in cell culture, and Dr Yiping Jing and Dr Yangxin Zhao for the discussion. This work was supported by the grants from the Key Programs of the National Natural Science Foundation of China (No. 30330350), Hi-Tech Research Development Program of China (863 Program, No. 2007AA021006), the Key Project of the Chinese Academy of Sciences (No. KSCX2-YW-R-09), and Shanghai Committee of Science and Technology (No. 04XD14015).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to X Y Liu or X Zhao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gan, Y., Gu, J., Cai, X. et al. Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo. Cancer Gene Ther 15, 808–816 (2008). https://doi.org/10.1038/cgt.2008.52

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2008.52

Keywords

This article is cited by

Search

Quick links